Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Artiva Biotherapeutics (ARTV) Cash from Investing Activities (2023 - 2025)

Artiva Biotherapeutics (ARTV) has disclosed Cash from Investing Activities for 3 consecutive years, with $16.0 million as the latest value for Q4 2025.

  • For Q4 2025, Cash from Investing Activities rose 1760.46% year-over-year to $16.0 million; the TTM value through Dec 2025 reached $63.4 million, up 152.64%, while the annual FY2025 figure was $63.4 million, 152.64% up from the prior year.
  • Cash from Investing Activities hit $16.0 million in Q4 2025 for Artiva Biotherapeutics, down from $16.3 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $21.1 million in Q2 2025 and bottomed at -$130.6 million in Q3 2024.
  • Average Cash from Investing Activities over 3 years is -$6.0 million, with a median of $5.6 million recorded in 2024.
  • Year-over-year, Cash from Investing Activities crashed 26396.55% in 2024 and then skyrocketed 1760.46% in 2025.
  • Artiva Biotherapeutics' Cash from Investing Activities stood at -$2.7 million in 2023, then skyrocketed by 63.79% to -$966000.0 in 2024, then surged by 1760.46% to $16.0 million in 2025.
  • According to Business Quant data, Cash from Investing Activities over the past three periods came in at $16.0 million, $16.3 million, and $21.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.